Mingchen Health Co.,Ltd. (SHE:002919)
China · Delayed Price · Currency is CNY 16.45
-0.38 (-2.26%)
Sep 15, 2026, 2:05 PM CST
Mingchen Health Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 4,448 | 6,091 | 4,376 | 5,683 | 6,084 | 4,811 | |
Market Cap Growth | 9.87% | 39.18% | -23.00% | -6.58% | 26.45% | 3.66% |
Enterprise Value | 4,200 | 5,970 | 4,224 | 5,642 | 6,010 | 4,593 |
Last Close Price | 16.83 | 22.93 | 16.36 | 21.06 | 22.53 | 17.58 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | - | 215.16 | 93.67 | 80.77 | 239.62 | 36.04 |
Forward PE | - | 11.96 | 11.96 | 11.96 | 11.96 | 14.95 |
PS Ratio | 2.62 | 4.02 | 3.17 | 3.47 | 6.44 | 6.47 |
PB Ratio | 5.66 | 7.55 | 5.32 | 7.02 | 8.23 | 6.35 |
P/TBV Ratio | 10.24 | 13.69 | 7.70 | 10.22 | 17.97 | 7.61 |
P/FCF Ratio | 69.32 | 5345.43 | 37.51 | 100.40 | - | 74.71 |
P/OCF Ratio | 35.56 | 69.49 | 26.48 | 82.00 | 83.05 | 60.24 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 2.47 | 3.94 | 3.06 | 3.45 | 6.36 | 6.17 |
EV/EBITDA Ratio | - | - | 58.40 | 25.70 | 351.34 | 38.37 |
EV/EBIT Ratio | - | - | 96.78 | 76.00 | - | 45.17 |
EV/FCF Ratio | 65.47 | 5239.35 | 36.21 | 99.67 | - | 71.32 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.10 | 0.14 | 0.03 | 0.07 | 0.12 | 0.03 |
Debt / EBITDA Ratio | - | 41.46 | 0.25 | 0.21 | 2.90 | 0.19 |
Debt / FCF Ratio | 1.20 | 97.39 | 0.20 | 0.94 | - | 0.38 |
Net Debt / Equity Ratio | -0.31 | -0.30 | -0.25 | -0.14 | -0.07 | -0.31 |
Net Debt / EBITDA Ratio | 5.13 | 22.85 | -2.88 | -0.53 | -3.21 | -1.99 |
Net Debt / FCF Ratio | -3.81 | -209.80 | -1.78 | -2.05 | 0.71 | -3.70 |
Asset Turnover | 1.43 | 1.27 | 1.16 | 1.30 | 0.85 | 0.81 |
Inventory Turnover | 10.24 | 9.26 | 4.63 | 3.30 | 2.82 | 2.80 |
Quick Ratio | 1.25 | 1.32 | 1.80 | 1.17 | 0.69 | 2.50 |
Current Ratio | 1.71 | 1.69 | 2.60 | 1.96 | 1.44 | 3.48 |
Return on Equity (ROE) | -2.57% | 3.41% | 5.72% | 9.08% | 3.39% | 18.89% |
Return on Assets (ROA) | -3.41% | -1.10% | 2.30% | 3.69% | -1.13% | 6.87% |
Return on Invested Capital (ROIC) | 32.12% | -1.84% | 6.67% | 10.77% | -3.33% | 22.59% |
Return on Capital Employed (ROCE) | -7.90% | -2.50% | 5.20% | 8.90% | -2.50% | 13.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | -0.40% | 0.46% | 1.07% | 1.24% | 0.42% | 2.77% |
FCF Yield | 1.44% | 0.02% | 2.67% | 1.00% | -1.27% | 1.34% |
Dividend Yield | 0.29% | 0.22% | 0.31% | 0.59% | - | 0.78% |
Payout Ratio | - | 48.69% | 71.21% | - | 144.32% | 24.19% |
Buyback Yield / Dilution | -0.20% | -0.02% | 1.52% | 2.25% | -3.70% | -0.43% |
Total Shareholder Return | 0.09% | 0.20% | 1.83% | 2.85% | -3.70% | 0.35% |